Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease
Liver International · 2023
DOI: 10.1111/liv.15595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Stine Johansen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Fibrosis, Fatty Liver and Steatohepatitis Research Center Odense (FLASH), Odense University Hospital, …. Hauptthemen laut MEDLINE: Camelids, New World, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020 Framework Programme, Novo Nordisk Fonden, Odense Universitetshospital.
Abstract (Originalsprache)
Background and Aims Risk prediction in alcohol‐related liver disease (ArLD) is an unmet need. We aimed to assess PRO‐C3 models to predict liver‐related events (LRE) in patients with a history of excessive alcohol use without an established diagnosis of chronic liver disease.
Methods
A prospective cohort study of 462 patients with ArLD, split into a derivation cohort of 221 secondary care patients and a validation cohort of 241 primary care patients. Baseline variables, including fibrogenesis marker PRO‐C3, were used to develop a prediction model. Prognostic accuracy was compared to enhanced liver fibrosis (ELF), fibrosis‐4‐index (FIB‐4), transient elastography (TE) and ADAPT.
Results
In the derivation and validation cohorts, 67 (30%) and 19 (8%) experienced an LRE during a median follow‐up of 5.2 years (IQR: 3.2‐6.8) and 4.0 years (IQR: 2.7‐5.6). On top of PRO‐C3 and ADAPT score, we generated a model (ALPACA) of independent predictors of LREs (PRO‐C3, AST/ALT, platelets). ALPACA had high prognostic accuracy with a C ‐statistic of 0.85 in the derivation cohort, comparable to ELF (0.83) and TE (0.84) and significantly higher than FIB‐4 (0.78), PRO‐C3 (0.80) and ADAPT (0.81). In the validation cohort, all tests had comparable C ‐statistics. Compared to low‐risk patients (ALPACA ≤11), high‐risk patients (>11) had a subhazard ratio for LREs of 12.6 (95% CI 5.9‐26.8, p < .001) and higher cumulative incidence (57% vs. 7%, p < .001; derivation cohort). We observed similar subhazard ratio in the validation cohort.
Conclusions
PRO‐C3‐based scores are reliable tools to predict LREs in ArLD patients and are suitable for risk stratification in primary and secondary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Fibrosis, Fatty Liver and Steatohepatitis Research Center Odense (FLASH), Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
- Nordic Bioscience A/S, Herlev Hovedgade, Herlev, Denmark.
- Department of Pathology, Odense University Hospital, Odense, Denmark.
- Department of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Stine Johansen, Mads Israelsen, Ida F Villesen, Nikolaj Torp, Mette J Nielsen, Maria Kjaergaard, Katrine P Lindvig, Camilla D Hansen, Ditlev N Rasmussen, Sönke Detlefsen, Diana J Leeming, Maja Thiele, Morten Karsdal, Aleksander Krag
Förderung
- Horizon 2020 Framework Programme
- Novo Nordisk Fonden
- Odense Universitetshospital
- Siemens
- Syddansk Universitet
- Toyota Foundation
Zitieren
APA
Johansen, S., Israelsen, M., Villesen, I. F., Torp, N., Nielsen, M. J., Kjaergaard, M., Lindvig, K. P., Hansen, C. D., Andersen, P., Rasmussen, D. N., Detlefsen, S., Leeming, D. J., Thiele, M., Karsdal, M., Krag, A., & GALAXY and MicrobLiver consortia (2023). Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease. Liver International. https://doi.org/10.1111/liv.15595
Vancouver
Johansen S, Israelsen M, Villesen IF, Torp N, Nielsen MJ, Kjaergaard M, et al. Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease. Liver International. 2023. doi:10.1111/liv.15595
BibTeX
@article{Johansen2023,
author = {Johansen, Stine and Israelsen, Mads and Villesen, Ida F and Torp, Nikolaj and Nielsen, Mette J and Kjaergaard, Maria and Lindvig, Katrine P and Hansen, Camilla D and Andersen, Peter and Rasmussen, Ditlev N and Detlefsen, Sönke and Leeming, Diana J and Thiele, Maja and Karsdal, Morten and Krag, Aleksander and GALAXY and MicrobLiver consortia, GALAXY and MicrobLiver consortia},
title = {Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15595}
}
EUVIMED